COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy.

Ailabouni, Nagham J; Hilmer, Sarah N; Kalisch, Lisa; Braund, Rhiannon; Reeve, Emily

Ailabouni, Nagham J; Hilmer, Sarah N; Kalisch, Lisa; Braund, Rhiannon; Reeve, Emily.

Ailabouni NJ; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide.
Hilmer SN; Kolling Institute of Medical Research, Royal North Shore Hospital and Northern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, New South Wales, Australia.
Kalisch L; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide.
Braund R; Department of Preventive and Social Medicine, New Zealand Pharmacovigilance Centre, University of Otago, Dunedin.
Reeve E; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide.

J Gerontol A Biol Sci Med Sci ; 76(6): 1068-1073, 2021 05 22.

Article in English | MEDLINE | ID: covidwho-143768

Subject(s)

COVID-19; Drug Therapy/standards; Drug Utilization/standards; Multimorbidity; Polypharmacy; Age Factors; Aged; Geriatrics; Humans; Patient Safety

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polypharmacy / Drug Therapy / Drug Utilization / Multimorbidity / COVID-19 Limits: Aged / Humans Language: English Journal: J Gerontol A Biol Sci Med Sci Journal subject: Geriatrics Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google